Markets:

Overview

News

Currencies

International

Treasuries

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

312.38 -2.37 (-0.75%)

Streaming Delayed Price Updated: 10:05 AM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Praxis Precision Medicines, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position ↗

November 20, 2025

Via Stocktwits

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 06, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Why Did Praxis Precision Medicines Stock Surge 69% In Pre-Market Today? ↗

October 16, 2025

Via Stocktwits

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

November 05, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results

November 05, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback

November 04, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 03, 2025

Via Benzinga

Meet the Biotech Stock That Just Jumped 251% Higher ↗

October 26, 2025

Find out what sent this typically overlooked stock through the roof.

Via The Motley Fool

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket ↗

October 17, 2025

Via Benzinga

Praxis Precision Stock Extends Rally Premarket As Wall Street Turns Hyper-Bullish After Essential Tremor Trial Win ↗

October 17, 2025

Wall Street boosted the stock’s price targets after the company’s late-stage trial for its essential tremor drug, ulixacaltamide, delivered strong efficacy and safety data.

Via Stocktwits

Topics Death

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

October 16, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

October 16, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 16, 2025

Via Benzinga

Dow Dips Over 100 Points; US Crude Oil Inventories Surge ↗

October 16, 2025

Via Benzinga

Topics Stocks

The 'Groundbreaking' Results That Sent Praxis Precision Medicines Up 200% ↗

October 16, 2025

The company is working on a treatment for essential tremor. Positive results shocked investors following a negative readout in February.

Via Investor's Business Daily

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗

October 16, 2025

Via Benzinga

Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings ↗

October 16, 2025

Via Benzinga

Topics Stocks

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 16, 2025

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 16, 2025

Via Benzinga

Praxis Precision Medicines Stock Doubles - Here's Why ↗

October 16, 2025

Praxis stock jumps after Phase 3 trials show ulixacaltamide significantly improves essential tremor symptoms and meets key efficacy endpoints.

Via Benzinga

Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor

October 16, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 02, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Praxis Precision Medicines, Inc. on Behalf of Praxis Stockholders and Encourages Investors to Contact the Firm

September 15, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX

September 14, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX

September 10, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX

September 06, 2025

From Pomerantz LLP

Via GlobeNewswire

Praxis Precision Medicines to Participate in September Investor Conferences

September 04, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Praxis, Align, Lantheus, and Spirit and Encourages Investors to Contact the Firm

September 04, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.